| Literature DB >> 21385671 |
Jaime Madrigano1, Andrea Baccarelli, Murray A Mittleman, Robert O Wright, David Sparrow, Pantel S Vokonas, Letizia Tarantini, Joel Schwartz.
Abstract
BACKGROUND: DNA methylation is a potential pathway linking environmental exposures to disease. Exposure to particulate air pollution has been associated with increased cardiovascular morbidity and mortality, and lower blood DNA methylation has been found in processes related to cardiovascular morbidity.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21385671 PMCID: PMC3222977 DOI: 10.1289/ehp.1002773
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Baseline characteristics of subjects in the NAS [n = 706; mean ± SD or n (%)].
| Table 1. Baseline characteristics of subjects in the NAS [ | |
| Characteristic | Baseline visit |
| Age (years) | 72.2 ± 6.8 |
| BMI (kg/m2) | 28.3 ± 4.1 |
| Obesity | 191 (27.1) |
| Smoking status | |
| Never | 201 (28.5) |
| Former | 475 (67.3) |
| Current | 30 (4.2) |
| Cumulative smoking (pack-years) | 30.0 ± 27.4 |
| Alcohol consumption | |
| < 2 drinks per day | 577 (81.7) |
| ≥ 2 drinks per day | 129 (18.3) |
| Taking diabetes medication | 60 (8.5) |
| Taking hypertensive medication | 411 (58.2) |
| Taking statin medication | 247 (35.0) |
| DNA methylation (% 5mC) | |
| LINE-1 | 77.5 ± 2.5 |
| Alu | 26.1 ± 1.1 |
| 368 (52.1) | |
| rs1695, any variant | 347 (49.2) |
| rs1799811, any variant | 90 (12.7) |
| 130 (18.4) | |
Change in LINE-1 and Alu methylation (%5mC) associated with an IQR increase in pollutant.
| Table 2. Change in LINE-1 and Alu methylation (%5mC) associated with an IQR increase in pollutant. | ||||||
| β-Coefficient | ||||||
| Exposure (average) | LINE-1 | Alu | IQR (µg/m3) | |||
| PM2.5 | ||||||
| 28 days | –0.01 (–0.16 to 0.13) | 0.00 (–0.10 to 0.09) | 3.33 | |||
| 45 days | –0.04 (–0.18 to 0.11) | 0.02 (–0.08 to 0.11) | 2.97 | |||
| 60 days | –0.05 (–0.20 to 0.10) | 0.03 (–0.07 to 0.13) | 2.66 | |||
| 90 days | 0.03 (–0.12 to 0.18) | 0.03 (–0.07 to 0.13) | 2.32 | |||
| 180 days | 0.07 (–0.05 to 0.19) | 0.07 (–0.01 to 0.15) | 1.53 | |||
| BC | ||||||
| 28 days | –0.22 (–0.43 to –0.01)* | –0.03 (–0.17 to 0.10) | 0.27 | |||
| 45 days | –0.31 (–0.57 to –0.05)* | –0.17 (–0.34 to 0.00)* | 0.27 | |||
| 60 days | –0.29 (–0.56 to –0.02)* | –0.21 (–0.39 to –0.03)* | 0.25 | |||
| 90 days | –0.21 (–0.50 to 0.09) | –0.31 (–0.50 to –0.12)* | 0.24 | |||
| 180 days | 0.20 (–0.16 to 0.55) | –0.10 (–0.33 to 0.13) | 0.21 | |||
| SO4 | ||||||
| 28 days | –0.14 (–0.30 to 0.02) | 0.02 (–0.09 to 0.13) | 1.04 | |||
| 45 days | –0.17 (–0.36 to 0.02) | –0.08 (–0.21 to 0.05) | 0.93 | |||
| 60 days | –0.21 (–0.43 to 0.01) | –0.03 (–0.18 to 0.12) | 0.93 | |||
| 90 days | –0.27 (–0.52 to –0.02)* | –0.03 (–0.20 to 0.13) | 0.83 | |||
| 180 days | –0.13 (–0.37 to 0.11) | –0.05 (–0.21 to 0.10) | 0.59 | |||
| CI, confidence interval. | ||||||
Figure 1Association between BC and Alu according to time window of exposure and GSTM1 genotype.